India is considering resuming exports of COVID-19 vaccines soon, mainly to Africa, Reuters news agency reported on Wednesday.
A source with knowledge of the matter told Reuters that this comes as India has partly immunised a majority of its adults and supplies have surged.
"The export decision is a done deal," said the source, who declined to be named as he was not authorised to talk to the media on the matter.
"India wants to help out Africa with both vaccines and its COVID operational model."
India, reportedly the world's biggest vaccines manufacturer, had stopped vaccine exports in April 2021 to focus on vaccinating its own population as COVID-19 infections surged.
The Indian government plans to vaccinate all of its 944 million adults by December 2021 and has so far given at least one dose to 61% of them.
Before India stopped its exports, it had donated or sold 66 million COVID-19 vaccine doses to nearly 100 countries, Reuters added.
Virbac expands presence in Japan with Sasaeah acquisition
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV
US CDC advisory committee backs Valneva's chikungunya vaccine
Takeda and Biological E. Limited join forces to combat global dengue threat
SK bioscience 'SKYTyphoid' receives WHO prequalification certification
ImmunityBio advances cancer vaccine trial for Lynch syndrome participants
AstraZeneca boosts vaccine portfolio with acquisition of Icosavax
Ultimovacs gains EMA Orphan Drug status for UV1 cancer vaccine in mesothelioma